Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,100
Closed -$579K 105
2024
Q3
$579K Sell
5,100
-700
-12% -$83.2K 0.17% 102
2024
Q2
$718K Sell
5,800
-3,400
-37% -$438K 0.13% 118
2024
Q1
$1.21M Buy
9,200
+5,200
+130% +$641K 0.04% 125
2023
Q4
$436K Sell
4,000
-1,300
-25% -$135K 0.02% 284
2023
Q3
$546K Sell
5,300
-300
-5% -$32.3K 0.04% 244
2023
Q2
$646K Sell
5,600
-1,400
-20% -$159K 0.03% 210
2023
Q1
$745K Buy
7,000
+1,700
+32% +$184K 0.02% 216
2022
Q4
$588K Sell
5,300
-11,700
-69% -$1.2M 0.06% 243
2022
Q3
$33K Buy
+17,000
New +$1.52M 0.02% 265
2022
Q1
Sell
-68,900
Closed -$40K 441
2021
Q4
$40K Buy
68,900
+39,400
+134% +$3.14M ﹤0.01% 341
2021
Q3
$44K Sell
29,500
-13,000
-31% -$989K 0.02% 299
2021
Q2
$61K Buy
+42,500
New +$3.16M 0.03% 284
2020
Q1
Sell
-11,842
Closed -$29K 267
2019
Q4
$29K Sell
11,842
-5,345
-31% -$439K ﹤0.01% 190
2019
Q3
$19K Buy
+17,187
New +$1.38M ﹤0.01% 193
2019
Q2
Sell
-13,100
Closed -$39K 327
2019
Q1
$39K Hold
13,100
0.01% 204
2018
Q4
$26K Buy
+13,100
New +$925K 0.01% 247

Other funds holding MRK

XR Securities's MRK Position: Q4 2024 in Review

XR Securities sold out of Merck (MRK) in Q4 2024, closing a stake of 1,789 shares — an estimated $203K sold.

XR Securities first reported a position in MRK in Q1 2019 and held it in 11 quarters. The position peaked at $764K in Q1 2019. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • XR Securities reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • XR Securities sold 1,789 Merck shares in Q4 2024, an estimated $203K.
  • XR Securities first reported a position in Merck in Q1 2019 and held it in 11 quarters.
  • XR Securities's Merck position peaked at $764K in Q1 2019.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on XR Securities's 13F filing for Q4 2024, filed 17 Jan 2025.